Dr. Heather Preston

Dr. Heather Preston was appointed to the Board as a Non-Executive Director in March 2018 and was appointed Chair of the Remuneration Committee in June 2020. Dr. Preston is also on the board of Oxford Nanopore Technologies plc and of Aligos Therapeutics, a Nasdaq listed company. In addition, she is a Senior Advisor to TPG Biotech. She has over 30 years of experience in healthcare, as a scientist, physician and management consultant and she has been an investor in life sciences and biotechnology for more than 20 years. Over the course of her career, Dr Preston has also served as a Director on the Boards of Oxford Science Enterprises plc, Karuna Pharmaceuticals and Akouos Inc. Dr. Preston holds a degree in Medicine from the University of Oxford.

Committee Membership:

• Remuneration Committee (Chair)
• Audit Committee
• Nomination Committee
• Scientific and Technology Advisory Committee

Relevant Skills:

• Scientific advisory
• Corporate finance
• Investor relations